Jacquelyn O. Wolff

Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial

A. Giobbie-Hurder, R. Sullivan, P. Ott, 2021, Journal for ImmunoTherapy of Cancer.

Landscape of helper and regulatory antitumour CD4+ T cells in melanoma

Charles H. Yoon, Shuqiang Li, K. Livak, 2022, Nature.

Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity.

C. Paweletz, M. Tolstorukov, E. V. Van Allen, 2021, Cancer discovery.

Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma

Keegan D. Korthauer, John G Doench, Shuqiang Li, 2022, The Journal of clinical investigation.

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse

Michal Sheffer, Catherine J. Wu, J. Ritz, 2022, The Journal of clinical investigation.

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.

Shuqiang Li, K. Livak, D. Neuberg, 2023, Blood.

Ipilimumab plus decitabine for patients with MDS or AML in post-transplant or transplant naïve settings.

D. Neuberg, Catherine J. Wu, J. Ritz, 2022, Blood.

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

C. Paweletz, D. Kallogjeri, J. Piccirillo, 2023, Science Immunology.